Arrowhead Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
With a market cap of 9.14B, Arrowhead Pharmaceuticals(ARWR) trades at $67.30. The stock has a price-to-earnings ratio of -1036.01.
As of 2025-12-30, Arrowhead Pharmaceuticals(ARWR) stock has fluctuated between $65.94 and $69.88. The current price stands at $67.30, placing the stock +2.1% above today's low and -3.7% off the high.
Arrowhead Pharmaceuticals(ARWR) shares are trading with a volume of 1.33M, against a daily average of 1.96M.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $72.36 and a 52-week low of $9.57.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $72.36 and a 52-week low of $9.57.
ARWR News
Why Arrowhead’s latest FDA win matters for the stock Arrowhead Pharmaceuticals (ARWR) just picked up FDA Breakthrough Therapy designation for plozasiran in sev...
